<?xml version="1.0" encoding="UTF-8"?>
<Document>
<TEXT><NODE id="0" />IV Equipment<NODE id="12" /> Market Expected to Witness a CAGR of 5.0% During 2017-2022.

Bild vergößern
(Presseportal <NODE id="103" />openBroadcast<NODE id="116" />) - Rising cases of needle stick injuries, the shift in demand towards ambulatory surgical centers and <NODE id="219" />fusion pumps<NODE id="231" />, and a greater number of surgical procedures performed are poised to benefit the <NODE id="313" />IV equipment<NODE id="325" /> market. Further more, a prevalence of chronic diseases in an ageing population in developed nations are positive signs for the <NODE id="453" />IV equipment<NODE id="465" /> market. However, lack of wireless connectivity, regulatory mandates for new product launches and increasing cases of medication errors inhibit the unencumbered growth of the <NODE id="640" />IV equipment<NODE id="652" /> market that is anticipated to witness a steady CAGR of 5% from 2017 to 2022.
Request to Download and View Full TOC @ https://www.persistencemarketresearch.com/market-research/iv-equipment-market/toc
The <NODE id="856" />IV catheter<NODE id="867" /> segment is the most popular in the <NODE id="903" />IV equipment<NODE id="915" /> market and should remain so for the foreseeable future. The <NODE id="976" />IV catheter<NODE id="987" /> segment is expected to be worth more than US$ 2.7 billion in 2017 itself and companies are recommended to target this segment with gusto. The <NODE id="1130" />infusion pump<NODE id="1143" /> segment is a close second in the <NODE id="1177" />IV equipment<NODE id="1189" /> market in terms of product type segment and is likely to be the biggest winner in terms of market share. Key stakeholders in the <NODE id="1319" />IV equipment<NODE id="1331" /> market would do well to focus their energy on the Europe <NODE id="1389" />infusion pumps<NODE id="1403" /> market as the region accounts for more than a third of the revenue contribution
The <NODE id="1488" />securement device<NODE id="1505" /> segment and <NODE id="1518" />stopclocks &amp; valve<NODE id="1536" /> segment have single digit revenue share in the <NODE id="1584" />IV equipment<NODE id="1596" /> market. While the <NODE id="1615" />former<NODE id="1621" /> is projected to lose market share, the <NODE id="1661" />latter<NODE id="1667" /> is on track to gain share and companies may seek to take advantage of this. The <NODE id="1748" />stopcock &amp; valves<NODE id="1765" /> segment is estimated to grow with a CAGR of just under 6% from 2017 to 2022. Along with Europe, the <NODE id="1866" />stopcocks &amp; valves<NODE id="1884" /> segment has strong potential in APEJ
Request to View Sample Report @ https://www.persistencemarketresearch.com/samples/19297
The <NODE id="2014" />drip chamber<NODE id="2026" /> and <NODE id="2031" />needleless connector<NODE id="2051" /> segment have a revenue share of less than a tenth in the <NODE id="2109" />IV equipment<NODE id="2121" /> market at the end of 2017. The <NODE id="2153" />needleless connector<NODE id="2173" /> segment is predicted to lose substantial share in the near future while the <NODE id="2250" />drip chamber<NODE id="2262" /> segment should fall slowly. The Europe <NODE id="2302" />drip chamber<NODE id="2314" /> segment is assessed to grow past more than US$ 285 million at the end of the forecast period. The <NODE id="2413" />needleless connector<NODE id="2433" /> segment also has the greatest potential in Europe. Along with Europe, companies could additionally target the North America <NODE id="2558" />needleless connector<NODE id="2578" /> segment
Hospitals hold the lion’s share in the <NODE id="2626" />IV equipment<NODE id="2638" /> market by end user segment and are forecast to hold steady for the medium to long term. Hospitals are the most-well equipped to deal with any and every patient need pertaining to IV treatment. Europe is the largest region in the hospital segment of the <NODE id="2892" />IV equipment<NODE id="2904" /> market but there is a close competition for the second place between APEJ and North America
The <NODE id="3001" />companies<NODE id="3010" /> profiled in the <NODE id="3027" />IV equipment<NODE id="3039" /> market are <NODE id="3051" />AngioDynamics<NODE id="3064" />, <NODE id="3066" />Moog Inc.<NODE id="3075" />, <NODE id="3077" />Terumo Corporation<NODE id="3095" />, <NODE id="3097" />C. R. Bard<NODE id="3107" />, <NODE id="3109" />ICU Medical<NODE id="3120" />, <NODE id="3122" />Smiths Group<NODE id="3134" />, <NODE id="3136" />Baxter International Inc.<NODE id="3161" />, <NODE id="3163" />Fresenius SE &amp; Co.<NODE id="3181" />, <NODE id="3183" />B. Braun Melsungen AG<NODE id="3204" />, and <NODE id="3210" />Becton, Dickinson and Company<NODE id="3239" />
Buy Full <NODE id="3249" />IV Equipment Market Report<NODE id="3275" /> @  https://www.persistencemarketresearch.com/checkout/19297
 
Firmenportrait:
<NODE id="3354" />Future Market Insights<NODE id="3376" /> (<NODE id="3378" />FMI<NODE id="3381" />) is a leading <NODE id="3396" />market intelligence<NODE id="3415" /> and <NODE id="3420" />consulting<NODE id="3430" /> <NODE id="3431" />firm<NODE id="3435" />. <NODE id="3437" />We<NODE id="3439" /> <NODE id="3440" />deliver<NODE id="3447" /> <NODE id="3448" />syndicated research reports<NODE id="3475" />, <NODE id="3477" />custom research reports<NODE id="3500" /> and <NODE id="3505" />consulting services<NODE id="3524" />, which are personalized in nature.
Bitte beachten Sie, dass für den Inhalt der hier veröffentlichten Meldung nicht <NODE id="3640" />openBroadcast<NODE id="3653" /> verantwortlich ist, sondern der Verfasser der jeweiligen Meldung selbst. AGB | Haftungsausschluss .

</TEXT>
<Meta>
<feature featureName="id" featureValue="http://www.openbroadcast.de/article/506157/iv-equipment-market-expected-to-witness-a-cagr-of-5.0-during-2017-2022.html@2017-10-20T12:29:41.000+02:00" />
<feature featureName="uri" featureValue="http://www.openbroadcast.de/article/506157/iv-equipment-market-expected-to-witness-a-cagr-of-5.0-during-2017-2022.html" />
<feature featureName="lang" featureValue="en" /></Meta><Entities>
<Entity id="0" startPos="0" endPos="12" type="product" surface="IV Equipment" />
<Entity id="1" startPos="103" endPos="116" type="organization" surface="openBroadcast" />
<Entity id="2" startPos="219" endPos="231" type="product" surface="fusion pumps" />
<Entity id="3" startPos="313" endPos="325" type="product" surface="IV equipment" />
<Entity id="4" startPos="453" endPos="465" type="product" surface="IV equipment" />
<Entity id="5" startPos="640" endPos="652" type="product" surface="IV equipment" />
<Entity id="6" startPos="856" endPos="867" type="product" surface="IV catheter" />
<Entity id="7" startPos="903" endPos="915" type="product" surface="IV equipment" />
<Entity id="8" startPos="976" endPos="987" type="product" surface="IV catheter" />
<Entity id="9" startPos="1130" endPos="1143" type="product" surface="infusion pump" />
<Entity id="10" startPos="1177" endPos="1189" type="product" surface="IV equipment" />
<Entity id="11" startPos="1319" endPos="1331" type="product" surface="IV equipment" />
<Entity id="12" startPos="1389" endPos="1403" type="product" surface="infusion pumps" />
<Entity id="13" startPos="1488" endPos="1505" type="product" surface="securement device" />
<Entity id="14" startPos="1518" endPos="1536" type="product" surface="stopclocks &amp; valve" />
<Entity id="15" startPos="1584" endPos="1596" type="product" surface="IV equipment" />
<Entity id="16" startPos="1615" endPos="1621" type="product" surface="former" />
<Entity id="17" startPos="1661" endPos="1667" type="product" surface="latter" />
<Entity id="18" startPos="1748" endPos="1765" type="product" surface="stopcock &amp; valves" />
<Entity id="19" startPos="1866" endPos="1884" type="product" surface="stopcocks &amp; valves" />
<Entity id="20" startPos="2014" endPos="2026" type="product" surface="drip chamber" />
<Entity id="21" startPos="2031" endPos="2051" type="product" surface="needleless connector" />
<Entity id="22" startPos="2109" endPos="2121" type="product" surface="IV equipment" />
<Entity id="23" startPos="2153" endPos="2173" type="product" surface="needleless connector" />
<Entity id="24" startPos="2250" endPos="2262" type="product" surface="drip chamber" />
<Entity id="25" startPos="2302" endPos="2314" type="product" surface="drip chamber" />
<Entity id="26" startPos="2413" endPos="2433" type="product" surface="needleless connector" />
<Entity id="27" startPos="2558" endPos="2578" type="product" surface="needleless connector" />
<Entity id="28" startPos="2626" endPos="2638" type="product" surface="IV equipment" />
<Entity id="29" startPos="2892" endPos="2904" type="product" surface="IV equipment" />
<Entity id="30" startPos="3001" endPos="3010" type="trigger" surface="companies" />
<Entity id="31" startPos="3027" endPos="3039" type="product" surface="IV equipment" />
<Entity id="32" startPos="3051" endPos="3064" type="organization" surface="AngioDynamics" />
<Entity id="33" startPos="3066" endPos="3075" type="organization" surface="Moog Inc." />
<Entity id="34" startPos="3077" endPos="3095" type="organization" surface="Terumo Corporation" />
<Entity id="35" startPos="3097" endPos="3107" type="organization" surface="C. R. Bard" />
<Entity id="36" startPos="3109" endPos="3120" type="organization" surface="ICU Medical" />
<Entity id="37" startPos="3122" endPos="3134" type="organization" surface="Smiths Group" />
<Entity id="38" startPos="3136" endPos="3161" type="organization" surface="Baxter International Inc." />
<Entity id="39" startPos="3163" endPos="3181" type="organization" surface="Fresenius SE &amp; Co." />
<Entity id="40" startPos="3183" endPos="3204" type="organization" surface="B. Braun Melsungen AG" />
<Entity id="41" startPos="3210" endPos="3239" type="organization" surface="Becton, Dickinson and Company" />
<Entity id="42" startPos="3249" endPos="3275" type="product" surface="IV Equipment Market Report" />
<Entity id="43" startPos="3354" endPos="3376" type="organization" surface="Future Market Insights" />
<Entity id="44" startPos="3378" endPos="3381" type="organization" surface="FMI" />
<Entity id="45" startPos="3396" endPos="3415" type="product" surface="market intelligence" />
<Entity id="46" startPos="3420" endPos="3430" type="product" surface="consulting" />
<Entity id="47" startPos="3431" endPos="3435" type="trigger" surface="firm" />
<Entity id="48" startPos="3437" endPos="3439" type="organization" surface="We" />
<Entity id="49" startPos="3440" endPos="3447" type="trigger" surface="deliver" />
<Entity id="50" startPos="3448" endPos="3475" type="product" surface="syndicated research reports" />
<Entity id="51" startPos="3477" endPos="3500" type="product" surface="custom research reports" />
<Entity id="52" startPos="3505" endPos="3524" type="product" surface="consulting services" />
<Entity id="53" startPos="3640" endPos="3653" type="organization" surface="openBroadcast" /></Entities><Relations>
<Relation id="54" NAME="CompanyProvidesProduct">
<Entity id="31" label="product" />
<Entity id="37" label="company" />
<Entity id="30" label="trigger" />
</Relation>
<Relation id="55" NAME="CompanyProvidesProduct">
<Entity id="31" label="product" />
<Entity id="36" label="company" />
<Entity id="30" label="trigger" />
</Relation>
<Relation id="56" NAME="CompanyProvidesProduct">
<Entity id="31" label="product" />
<Entity id="35" label="company" />
<Entity id="30" label="trigger" />
</Relation>
<Relation id="57" NAME="CompanyProvidesProduct">
<Entity id="31" label="product" />
<Entity id="38" label="company" />
<Entity id="30" label="trigger" />
</Relation>
<Relation id="58" NAME="CompanyProvidesProduct">
<Entity id="31" label="product" />
<Entity id="34" label="company" />
<Entity id="30" label="trigger" />
</Relation>
<Relation id="59" NAME="CompanyProvidesProduct">
<Entity id="31" label="product" />
<Entity id="39" label="company" />
<Entity id="30" label="trigger" />
</Relation>
<Relation id="60" NAME="CompanyProvidesProduct">
<Entity id="31" label="product" />
<Entity id="41" label="company" />
<Entity id="30" label="trigger" />
</Relation>
<Relation id="61" NAME="CompanyProvidesProduct">
<Entity id="31" label="product" />
<Entity id="33" label="company" />
<Entity id="30" label="trigger" />
</Relation>
<Relation id="62" NAME="CompanyProvidesProduct">
<Entity id="31" label="product" />
<Entity id="40" label="company" />
<Entity id="30" label="trigger" />
</Relation>
<Relation id="63" NAME="CompanyProvidesProduct">
<Entity id="31" label="product" />
<Entity id="32" label="company" />
<Entity id="30" label="trigger" />
</Relation>
<Relation id="64" NAME="CompanyProvidesProduct">
<Entity id="31" label="product" />
<Entity id="41" label="company" />
<Entity id="30" label="trigger" />
</Relation>
<Relation id="65" NAME="CompanyProvidesProduct">
<Entity id="45" label="product" />
<Entity id="46" label="product" />
<Entity id="43" label="company" />
<Entity id="47" label="trigger" />
</Relation>
<Relation id="66" NAME="CompanyProvidesProduct">
<Entity id="51" label="product" />
<Entity id="50" label="product" />
<Entity id="52" label="product" />
<Entity id="48" label="company" />
<Entity id="49" label="trigger" />
</Relation>
<Relation id="67" NAME="Identity">
<Entity id="0" label="source" />
<Entity id="15" label="target" />
<Entity id="10" label="target" />
<Entity id="4" label="target" />
<Entity id="5" label="target" />
<Entity id="31" label="target" />
<Entity id="3" label="target" />
<Entity id="22" label="target" />
<Entity id="11" label="target" />
<Entity id="28" label="target" />
<Entity id="7" label="target" />
<Entity id="29" label="target" />
</Relation>
<Relation id="68" NAME="Identity">
<Entity id="1" label="source" />
<Entity id="53" label="target" />
</Relation>
<Relation id="69" NAME="Identity">
<Entity id="2" label="source" />
<Entity id="12" label="target" />
</Relation>
<Relation id="70" NAME="Identity">
<Entity id="6" label="source" />
<Entity id="8" label="target" />
</Relation>
<Relation id="71" NAME="Identity">
<Entity id="13" label="source" />
<Entity id="16" label="target" />
</Relation>
<Relation id="72" NAME="Identity">
<Entity id="14" label="source" />
<Entity id="18" label="target" />
<Entity id="17" label="target" />
<Entity id="19" label="target" />
</Relation>
<Relation id="73" NAME="Identity">
<Entity id="20" label="source" />
<Entity id="25" label="target" />
<Entity id="24" label="target" />
</Relation>
<Relation id="74" NAME="Identity">
<Entity id="21" label="source" />
<Entity id="23" label="target" />
<Entity id="26" label="target" />
<Entity id="27" label="target" />
</Relation>
<Relation id="75" NAME="Identity">
<Entity id="43" label="source" />
<Entity id="44" label="target" />
<Entity id="48" label="target" />
</Relation>
<Relation id="76" NAME="Identity">
<Entity id="46" label="source" />
<Entity id="52" label="target" />
</Relation></Relations>
</Document>
